Literature DB >> 26874728

HSPB1 polymorphisms might be associated with radiation-induced damage risk in lung cancer patients treated with radiotherapy.

Xiaofeng Li1, Sheng Xu1, Yu Cheng1, Jun Shu2.   

Abstract

Several studies investigating the association between heat shock protein beta-1 (HSPB1) polymorphisms and radiation-induced damage in lung cancer patients administrated with radiotherapy have derived conflicting results. This meta-analysis aimed to assess the association between the HSPB1 genes' (rs2868370 and rs2868371) polymorphisms and the risk of radiation-induced damage in lung cancer patients. After an electronic literature search, four articles including six studies were found to be eligible for this meta-analysis. No association was observed between rs2868370 genotypes and radiation-induced damage risk. However, rs2868371 showed a statistically increased risk of radiation-induced damage under CC vs. CG/GG model (OR = 1.59, 95 % CI = 1.10-2.29). Subgroup analysis by ethnicity showed that the genotypes of rs2868371 were also associated with a significantly increased risk of radiation-induced damage in CC vs. CG/GG model (OR = 1.86, 95 % CI = 1.21-2.83) among mixed ethnicities which are mainly comprised of white people. When the data was stratified by organ-damaged, a significant association was only observed in the esophagus group (OR = 2.94, 95 % CI = 1.35-6.37, for CC vs. CG/GG model). In conclusion, the present study demonstrated that the rs2868371 genotypes of HSPB1 might be associated with radiation-induced esophagus damage risk, especially in Caucasians but not in the Asian population.

Entities:  

Keywords:  Damage; HSPB1; Lung cancer; Polymorphism; Radiotherapy

Mesh:

Substances:

Year:  2016        PMID: 26874728     DOI: 10.1007/s13277-016-4959-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

1.  Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy.

Authors:  Jose Luis Lopez Guerra; Qingyi Wei; Xianglin Yuan; Daniel Gomez; Zhensheng Liu; Yan Zhuang; Ming Yin; Minghuan Li; Li-E Wang; James D Cox; Zhongxing Liao
Journal:  Radiother Oncol       Date:  2011-09-19       Impact factor: 6.280

Review 2.  On the role of Hsp27 in regulating apoptosis.

Authors:  C G Concannon; A M Gorman; A Samali
Journal:  Apoptosis       Date:  2003-01       Impact factor: 4.677

3.  Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study.

Authors:  Umberto Ricardi; Giovanni Frezza; Andrea Riccardo Filippi; Serena Badellino; Mario Levis; Piera Navarria; Fabrizio Salvi; Michela Marcenaro; Marco Trovò; Alessia Guarneri; Renzo Corvò; Marta Scorsetti
Journal:  Lung Cancer       Date:  2014-03-13       Impact factor: 5.705

Review 4.  Lung cancer.

Authors:  Roy S Herbst; John V Heymach; Scott M Lippman
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

Review 5.  Predictors and management of chest wall toxicity after lung stereotactic body radiotherapy.

Authors:  Talha Shaikh; Aruna Turaka
Journal:  Cancer Treat Rev       Date:  2014-09-16       Impact factor: 12.111

Review 6.  Prediction of radiation pneumonitis in lung cancer patients: a systematic review.

Authors:  Xiao-Jing Zhang; Jian-Guo Sun; Jie Sun; Hua Ming; Xin-Xin Wang; Lei Wu; Zheng-Tang Chen
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-29       Impact factor: 4.553

7.  Identification of heat shock protein 27 as a radioresistance-related protein in nasopharyngeal carcinoma cells.

Authors:  Bin Zhang; Jia-Quan Qu; Liang Xiao; Hong Yi; Peng-Fei Zhang; Mao-Yu Li; Rong Hu; Xun-Xun Wan; Qiu-Yan He; Jian-Huang Li; Xu Ye; Zhi-Qiang Xiao; Xue-Ping Feng
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-31       Impact factor: 4.553

8.  Altered cross-linking of HSP27 by zerumbone as a novel strategy for overcoming HSP27-mediated radioresistance.

Authors:  Seo-Hyun Choi; Yoon-Jin Lee; Woo Duck Seo; Hae-June Lee; Joo-Won Nam; Yoo Jin Lee; Joon Kim; Eun-Kyoung Seo; Yun-Sil Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-15       Impact factor: 7.038

9.  Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival.

Authors:  Huan Guo; Yun Bai; Ping Xu; Zhibin Hu; Li Liu; Fang Wang; Guangfu Jin; Feng Wang; Qifei Deng; Yixiao Tu; Maohui Feng; Daru Lu; Hongbing Shen; Tangchun Wu
Journal:  J Clin Oncol       Date:  2010-03-15       Impact factor: 44.544

Review 10.  Radiation-associated Cardiac Injury.

Authors:  Robert Eldabaje; Duong L Le; Wendy Huang; Li-Xi Yang
Journal:  Anticancer Res       Date:  2015-05       Impact factor: 2.480

View more
  2 in total

1.  The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy.

Authors:  Ting Zou; Jun-Yan Liu; Li She; Ji-Ye Yin; Xi Li; Xiang-Ping Li; Hong-Hao Zhou; Juan Chen; Zhao-Qian Liu
Journal:  Front Pharmacol       Date:  2020-07-21       Impact factor: 5.810

2.  Validation of Polymorphisms Associated with the Risk of Radiation-Induced Oesophagitis in an Independent Cohort of Non-Small-Cell Lung Cancer Patients.

Authors:  Miguel E Aguado-Barrera; Laura Martínez-Calvo; Juan Fernández-Tajes; Patricia Calvo-Crespo; Begoña Taboada-Valladares; Ramón Lobato-Busto; Antonio Gómez-Caamaño; Ana Vega
Journal:  Cancers (Basel)       Date:  2021-03-22       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.